ABSTRACT
No disponible
Subject(s)
Humans , Neoplasms/complications , Nutrition Disorders/epidemiology , Medical Oncology/trends , Comprehensive Health Care/trendsABSTRACT
No disponible
Subject(s)
Humans , Nutrition Disorders/physiopathology , Neoplasms/complications , Malnutrition/physiopathology , Anorexia/epidemiology , Protein-Energy Malnutrition/epidemiology , Cachexia/epidemiology , Weight Loss , Antineoplastic Agents/adverse effects , Radiotherapy/adverse effectsABSTRACT
No disponible
Subject(s)
Humans , Neoplasms/complications , Nutrition Disorders/epidemiology , Nutritional Status , Protein-Energy Malnutrition/complications , Quality of Life , Treatment Outcome , Drug Tolerance , Medication Adherence/statistics & numerical data , Indicators of Morbidity and Mortality , Cachexia/physiopathology , Health Care Costs/statistics & numerical dataABSTRACT
No disponible
Subject(s)
Humans , Neoplasms/complications , Nutrition Disorders/diagnosis , Nutrition Assessment , Nutritional Status , Malnutrition/diagnosis , Mass Screening/methods , Early Diagnosis , Weight Loss/physiology , Feeding and Eating Disorders/physiopathologyABSTRACT
No disponible
Subject(s)
Humans , Neoplasms/complications , Nutrition Disorders/epidemiology , Malnutrition/diet therapy , Nutrition Therapy/methods , Evaluation of Results of Therapeutic Interventions , Nutritional Support/methods , Risk Factors , Anorexia/diet therapy , Nausea/diet therapy , Constipation/diet therapy , Deglutition Disorders/diet therapyABSTRACT
No disponible
Subject(s)
Humans , Feeding and Eating Disorders/drug therapy , Appetite Stimulants/therapeutic use , Anorexia/drug therapy , Cachexia/drug therapy , Neoplasms/complications , Nutrition Disorders/epidemiology , Weight Loss , Progestins/therapeutic use , Adrenal Cortex Hormones/therapeutic useABSTRACT
No disponible
Subject(s)
Humans , Neoplasms/complications , Nutrition Disorders/epidemiology , Healthy Lifestyle , Nutrition Therapy/methods , Nutrients , Micronutrients/therapeutic use , Exercise Therapy , Practice Patterns, Physicians'ABSTRACT
Analizamos el tratamiento de las recidivas de glioblastoma multiforme y astrocitoma anaplásico con cirugíamás la implantación de polímeros de carmustina (BCNU) en el lecho de la recidiva, con el objetivo de mejorarla calidad de vida, los síntomas neurológicos y generales, y aumentar el control tumoral. Reflejamos la experienciay datos clínicos de 4 pacientes intervenidos.El empleo de carmustina implantes puede realizarse de forma factible sin objetivarse efectos adversos queinterfieran la calidad de vida, además de observar un enlentecimiento en la progresión del deterioro neurológicode los pacientes.La selección de pacientes jóvenes, con un buen performance estatus, en los que se prevea la mejor resecciónde la recidiva posible, garantizará el éxito en el tratamiento paliativo con implantes de carmostina
In recurrent glioblastoma multiforme and anaplastic astrocytoma, surgery and carmustine (NCNU) polymersimplants over the surgical area of the removed recidivation is a promising way to improve the quality of life,the neurologic and general symptoms, and the tumor control. We report our data and experience in fourpatients. The resection was optimized because the patients were young and showed a performance statusbetween 0 and 2
